Atlas Trials

Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

Clinical trial NCT02888197 · COMPLETED

Trial details

NCT number
NCT02888197
Sponsor
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status
COMPLETED
Study type
OBSERVATIONAL
Candidiasis, VulvovaginalYeast InfectionMycosesMoniliasis, VulvovaginalVaginitis, Monilial
Start date
2016-08-16
Primary completion
2017-03-15
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.